Table 1.
Characteristics of cohorts included in the cohort study and the nested case-control study.
| Data provider or institute | Study cohort | Data | Women invited (n=10,964) of total base cohorta (N=14,379), n/N | Questionnaires provided (N=6547), n | Serum samples provided (N=1640), n | Time period of data collection |
| DCOG LATER (Amsterdam UMC, Erasmus Medical Center Rotterdam)b, Netherlands | DCOG LATER cohortc [17] | PRd | 1684/2190 | 1109 | 619 | 2004-2014 |
| Netherlands Cancer Institute Amsterdam, Netherlands | Hodgkin Lymphoma cohort [19,21] | PR | 275/450 | 203 | 0 | 1997-2016 |
| Universitätsklinikum Bonn, Germany | VIVE cohortc | PR | 4467/5909 | 2482 | 0 | 2014-2015 |
| Westfaelische Wilhelms-Universitaet Muensterb, Germany | Ewing 2008 Clinical Trials cohort | DUe | 140/161 | 46 | 24 | 2015-2016 |
| Charité - Universitätsmedizin Berlin, Germany | Berlin Hormone Analyses cohortc [3] | PR | 344/402 | 83 | 69 | 2008-2009 |
| Fakultni nemocnice Brnob, Czech Republic | Cohort female 5-yr cancer survivors Brnoc | DU | 203/283 | 182 | 180 | 2015-2016 |
| Fakultni nemocnice v Motolb, Czech Republic | Cohort female 5-yr cancer survivors Motolc | DU | 1063/1398 | 574 | 301 | 2014-2016 |
| Istituto Giannina Gaslinib, Italy | Gaslini female survivors cohortc | DU | 814/1111 | 563 | 122 | 2015-2016 |
| University of Bern, Switzerland | Swiss Childhood Cancer Survivor Study cohort 1c [18] | PR | 977/1135 | 685 | 0 | 2007-2013 |
| University of Bern, Switzerland | Swiss Childhood Cancer Survivor Study cohort 2c [18] | PR | 228/335 | 113 | 0 | 2015-2016 |
| Great Ormond Street Children’s Hospital/University College London Hospitalc, United Kingdom | Hematopoietic stem cell transplantation cohortc | DU | 93/95 | 50 | 44 | 2015-2016 |
| Oslo University Hospitalb, Norway | Lymphoma survivor cohort [8] | PR | 82/Unknown | 51 | 46 | 2007-2009 |
| Oslo University Hospitalb, Norway | Acute lymphoblastic leukaemia survivor cohort [21] | PR | 103/175 | 82 | 65 | 2009-2010 |
| University hospital Saint-Étienneb, France | Rhone Alpe cohort 1c | PR | 120/212 | 120 | 35 | 2005-2013 |
| University hospital Saint-Étienneb, France | Rhone Alpe cohort 2c | PR | 220/284 | 102 | 62 | 2015-2016 |
| Edmond and Lily Safra Children's Hospital, Sheba Medical Centerb, Israel | The Edmond and Lily Safra Children's Hospital Late Effects cohortc | DU | 151/239 | 102 | 73 | 2015-2016 |
aBase cohort is the subjects fulfilling inclusion criteria of study.
bInstitutes participating in the nested case-control study.
cVarious cancer diagnoses.
dPR: data collected prior to PanCareLIFE project.
eDU: data collected during PanCareLIFE project.